DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Metastatic Prostate Cancer - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Prostate Cancer The report also ...
January 2020
60 pages
Metastatic Renal Cell Carcinoma (mRCC) - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Renal Cell Carcinoma (mRCC) The report also ...
January 2020
60 pages
Moderate Psoriasis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Moderate Psoriasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Moderate Psoriasis development. The report provides ...
January 2020
60 pages
Mucopolysaccharidosis III - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Mucopolysaccharidosis III - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Mucopolysaccharidosis III development. The report provides ...
January 2020
60 pages
Mycosis Fungoides - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Mycosis Fungoides - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Mycosis Fungoides development. The report provides ...
January 2020
60 pages
Neuroblastoma - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Neuroblastoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Neuroblastoma development. The report provides detailed ...
January 2020
60 pages
Neurofibromatoses - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Neurofibromatoses - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Neurofibromatoses development. The report provides detailed ...
January 2020
120 pages
Nicotine Addiction - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Nicotine Addiction - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nicotine Addiction development. The report provides ...
January 2020
60 pages
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non Alcoholic Fatty Liver Disease (NAFLD) The report also ...
January 2020
60 pages
Nosocomial Infections - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Nosocomial Infections - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nosocomial Infections development. The report provides ...
January 2020
60 pages
Oligodendroglioma - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Oligodendroglioma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Oligodendroglioma development. The report provides detailed ...
January 2020
90 pages
Opioid-Induced Constipation - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Opioid-Induced Constipation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Opioid-Induced Constipation development. The report provides ...
January 2020
120 pages
Optic Neuritis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Optic Neuritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Optic Neuritis development. The report provides ...
January 2020
60 pages
Oral Mucositis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Oral Mucositis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Oral Mucositis development. The report provides ...
January 2020
60 pages
Otitis Media - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Otitis Media - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Otitis Media development. The report provides ...
January 2020
60 pages
Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pancreatic Ductal Adenocarcinoma The report also ...
January 2020
60 pages
Pancreatic Endocrine Tumor - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pancreatic Endocrine Tumor The report also ...
January 2020
60 pages
Pancreatitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Pancreatitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pancreatitis development. The report provides detailed ...
January 2020
60 pages
Papillary Thyroid Cancer - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Papillary Thyroid Cancer The report also ...
January 2020
60 pages
Partial Seizure - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Partial Seizure - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Partial Seizure development. The report provides ...
January 2020
120 pages
Pemphigus Vulgaris - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Pemphigus Vulgaris - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pemphigus Vulgaris development. The report provides ...
January 2020
60 pages
Periodontal Disease - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Periodontal Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Periodontal Disease development. The report provides ...
January 2020
60 pages
Peripheral Neuropathic Pain - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Peripheral Neuropathic Pain The report also ...
January 2020
60 pages
Phenylketonuria (PKU) - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Phenylketonuria (PKU) - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Phenylketonuria (PKU) development. The report provides ...
January 2020
60 pages
Plague - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Plague - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Plague development. The report provides detailed ...
January 2020
60 pages
